We verified that there was no statistically significant difference of the positive rates (58.3% vs 85.7%) and equivocal negative rates (41.7% vs 14.3%) of the ice test between MG patients taking anti-cholinesterase inhibitors before the test and those who did not (p = 0.116, χ2 test). This evidence concerns the gene BCHE and myasthenia gravis.